CYP2C19: The Gene That Decides How You Process Certain Drugs
One liver enzyme, a big say in how some medications work for you.
CYP2C19 is a liver enzyme that breaks down a long list of common medications. For some of them, that breakdown step is what turns the drug on; for others, it's how your body clears the drug out. The same enzyme, doing opposite jobs depending on the drug. The variant we look at here, rs4244285, is the famous *2 allele. It carries an A where the working version carries a G, and that single letter change creates a faulty splice site that produces a stunted, non-working enzyme. If you carry one or two copies of the A, you make less functional CYP2C19, and a handful of important drugs behave differently in you than the labeling assumes. This page explains what your genotype means in plain terms. It is educational, not medical advice, and it is not a reason to change any medication on your own.
What CYP2C19 does
CYP2C19 is one of the cytochrome P450 enzymes in your liver. Its job is chemistry: it adds oxygen to drug molecules so they can be activated or eliminated.
For some drugs it's an activator. Clopidogrel (Plavix) arrives as a prodrug that does nothing until CYP2C19 converts it, in two steps, into the active form that actually stops platelets from clumping.
For other drugs it's a clearance route. Proton pump inhibitors like omeprazole, and several antidepressants, lean on CYP2C19 to be removed from the bloodstream.
The rs4244285 A allele (the *2 version) breaks the enzyme at the splicing stage, so the protein comes out truncated and inactive. Less working enzyme means activator drugs get switched on more weakly and clearance drugs build up higher.
How many A copies you carry sorts you into a metabolizer category: normal, intermediate, or poor. That category, not the drug dose alone, shapes how the medication lands.
Your variants, decoded
This is the most common loss-of-function version of CYP2C19. The reference (working) allele is G; the A allele is the broken *2 version. Count your A's to find your metabolizer category. Heads up: a 23andMe or AncestryDNA export reads the opposite DNA strand for this position, so it may print your result as C and T instead of G and A. C lines up with G, and T lines up with A, so a file showing CC, CT, or TT maps to GG, GA, and AA here.
| GG | Two working copies. You're a normal (extensive) metabolizer. Activator drugs like clopidogrel get switched on as expected, and CYP2C19-cleared drugs leave at the usual rate. This is the version most drug labels are written around. |
| GA | One working copy, one broken *2 copy. You're an intermediate metabolizer. You make somewhat less functional enzyme, so activator drugs may work a bit less and cleared drugs may run a bit higher than average. |
| AA | Two broken *2 copies. You're a poor metabolizer. You make little to no working CYP2C19. Activator drugs like clopidogrel are weakly activated, and CYP2C19-cleared drugs can climb to much higher levels than normal. |
Genotypes are shown order-insensitively and on the forward strand; your own export may print the complementary letters — the meaning is the same.
What the research suggests
CYP2C19 is a drug-metabolism gene, so the useful action here isn't taking something, it's making sure your prescribers know your metabolizer status before they choose or dose a CYP2C19 drug. In a controlled study of healthy volunteers, people carrying a reduced-function CYP2C19 allele formed about 32% less of the active clopidogrel metabolite than non-carriers, which is exactly the kind of pharmacokinetic difference a clinician accounts for when picking a drug or dose. No supplement changes the enzyme; the genotype is something to share, not treat.
PubMed 19106084 · in 162 healthy subjects, carriers of a reduced-function CYP2C19 allele had a 32.4% lower plasma exposure to the active metabolite of clopidogrel than non-carriers, confirming the A (*2) allele reduces CYP2C19 enzyme activity
Educational only — not medical advice. “General evidence” means the finding is real but the supplement’s benefit isn’t unique to your genotype.
See this matched to your own DNA — free.
Upload your 23andMe or AncestryDNA file and get your actual CYP2C19 result, plus every other actionable variant — each line cited, your file never stored.
Questions
My 23andMe file shows CC, CT, or TT for rs4244285, not GG, GA, or AA. Did I read the wrong gene?
No, it's the same spot. Consumer DNA files often report the opposite DNA strand for this position. C pairs with G and T pairs with A, so a file showing CC maps to GG (normal), CT maps to GA (intermediate), and TT maps to AA (poor metabolizer). The biology is identical; only the letters flipped.
Does this gene mean a drug won't work for me?
Not on its own. CYP2C19 status shifts how a drug behaves, but dose, your other medications, kidney and liver function, and the specific drug all matter too. For clopidogrel, a poor metabolizer may get less of the intended effect; for omeprazole, that same person may get a stronger effect at a standard dose. A clinician weighs all of it together.
Should I ask my doctor to switch my medication because of this result?
Bring the result to them, but let them make the call. There are published pharmacogenomic guidelines (CPIC, among others) that doctors and pharmacists use to interpret CYP2C19 genotype against specific drugs. A raw consumer file is a starting point for that conversation, not a verified clinical test, and self-adjusting a medication can be dangerous.
Is there a supplement that fixes a poor-metabolizer genotype?
No. You can't supplement your way to a different CYP2C19 enzyme, and anyone selling that is selling a story. The genotype is fixed. What you can do is make sure the people prescribing your medications know about it.
Does CYP2C19 affect anything besides clopidogrel and PPIs?
Yes. It also helps metabolize several SSRIs and other antidepressants, some anti-seizure drugs, and a few others. The principle is the same across them: less working enzyme changes the drug's levels or activation, and the direction depends on whether the enzyme turns the drug on or clears it out.